The high-stakes biological reset: how stem cell transplants rebuild immune systems
In short: Hematopoietic stem cell transplantation is a radical medical intervention reserved for life-threatening diseases. By destroying a patient's existing bone marrow and replacing it with new cells, doctors can effectively reboot the immune system. But this biological reset carries profound risks, from severe infection to the body attacking itself.
The procedure, known as HSCT, involves replacing a patient's hematopoietic stem cells using three primary methods: autologous (the patient's own cells), syngeneic (from an identical twin), or allogeneic (from a donor). In autologous transplants, cells are harvested, frozen using dimethyl sulfoxide, and later reinfused after the patient undergoes high-dose chemotherapy or radiation. This method is a standard second-line treatment for diseases like lymphoma because it avoids the risk of graft-versus-host disease.
Allogeneic transplants are more complex, requiring a precise match of Human Leukocyte Antigen (HLA) genes between donor and recipient. Even a single DNA base pair mismatch can be significant. While these transplants can provide a 'graft-versus-tumor' effect—where donor T-cells help eradicate remaining cancer—they also introduce the danger of graft-versus-host disease, where the new immune system attacks the recipient's tissues. To mitigate this, recipients often require immunosuppressive medications for at least six months.
The clinical utility of HSCT is expanding. Beyond treating leukemias and lymphomas, it is used for autoimmune diseases like multiple sclerosis and certain hereditary skeletal dysplasias. Newer 'mini' or nonmyeloablative transplants use lower doses of conditioning regimens, making the procedure accessible to elderly patients or those too weak for conventional treatment. Despite these advances, the procedure remains dangerous; the one-year survival rate is estimated at roughly 60%, as patients face severe risks including sepsis, mucositis, and opportunistic infections.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Hematopoietic stem cell transplantation
- Also: www.nhs.uk — Stem cell or bone marrow transplants
- Also: PloS one — Correction: Association of zinc deficiency with infectious complications in pediatric hematopoietic stem cell transplantation patients. · CC BY
- Also: Revista brasileira de enfermagem — Contextual analysis of hematopoietic stem cell transplantation in outpatients. · CC BY
To cite this card, link to https://intellectplus.co.uk/app/health-hematopoietic-stem-cell-transplantation.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics
